Early evaluation of the safety, tolerability and pharmacokinetics of a novel 5HT6 receptor full antagonist for the treatment of the symptoms of mild-to-moderate dementia of the Alzheimer type
Joanne Bell, Stephane Chalone, Tom Comery, Susan Baird-Bellaire, Myriam El Gaaloul, Alice Nichols, James KupiecVolume:
6
Year:
2010
Language:
english
DOI:
10.1016/j.jalz.2010.05.1000
File:
PDF, 62 KB
english, 2010